In this study, we found that Ly6GmiLy6CloCD11b+ CXCR2+ subsets (named CXCR2+ MDSCs) were predominately expanding and recruiting in systemic and local tumor microenvironment during breast cancer progression. The gene discussed is CXCR2; the disease is neoplasm.